{
  "denotations": [
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 13,
        "end": 45
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 48,
        "end": 52
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 68,
        "end": 94
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 97,
        "end": 102
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 158,
        "end": 162
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 158,
        "end": 191
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 194,
        "end": 198
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 194,
        "end": 204
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22521649_2",
  "text": "BACKGROUND : Epidermal growth factor receptor ( EGFR ) mutations in non-small cell lung cancer ( NSCLC ) are important predictive markers for the response to EGFR - tyrosine kinase inhibitors ( EGFR -TKIs ) ."
}
